Metabolic syndrome percentage was decreased in the metformin-insulin group (44.8 vs. 37.9%, p = 0.008) whereas it increased in the insulin alone group (41.4 vs. 44.8%, p = 0.035). Here, INS is linked to metabolic syndrome.